Analyzing Nutex Health (NASDAQ:NUTX) & Biocorrx (OTCMKTS:BICX)

Nutex Health (NASDAQ:NUTX) and Biocorrx (OTCMKTS:BICX) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, dividends, institutional ownership and risk.

Volatility and Risk

Nutex Health has a beta of -0.2, suggesting that its stock price is 120% less volatile than the S&P 500. Comparatively, Biocorrx has a beta of 0.05, suggesting that its stock price is 95% less volatile than the S&P 500.

Institutional and Insider Ownership

5.3% of Nutex Health shares are owned by institutional investors. 36.9% of Nutex Health shares are owned by company insiders. Comparatively, 21.4% of Biocorrx shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Analyst Ratings

This is a breakdown of current recommendations and price targets for Nutex Health and Biocorrx, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nutex Health	0	1	2	0	2.67
Biocorrx	0	1	0	0	2.00

Nutex Health presently has a consensus price target of $252.50, suggesting a potential upside of 101.08%. Given Nutex Health’s stronger consensus rating and higher probable upside, equities analysts plainly believe Nutex Health is more favorable than Biocorrx.

Earnings & Valuation

This table compares Nutex Health and Biocorrx”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nutex Health	$479.95 million	1.45	$52.18 million	$11.89	10.56
Biocorrx	$10,000.00	806.40	-$5.11 million	($0.35)	-1.14

Nutex Health has higher revenue and earnings than Biocorrx. Biocorrx is trading at a lower price-to-earnings ratio than Nutex Health, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Nutex Health and Biocorrx’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nutex Health	10.76%	42.08%	11.80%
Biocorrx	N/A	N/A	-130.26%

Summary

Nutex Health beats Biocorrx on 12 of the 14 factors compared between the two stocks.

About Nutex Health

Nutex Health Inc. operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment owns and owns and leases land and hospital building. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments which offers 24/7 care. It also provides operational and managerial services, including management, billing, collections, human resources and recruiting, legal, accounting, and marketing. In addition, the company offers healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; and onsite inpatient pharmacies. The company was founded in 2011 and is based in Houston, Texas.

About Biocorrx

BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.